Mostrando 2 resultados de: 2
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Tria
ArticleAbstract: Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation-3) found that antihypPalabras claves:Blood pressure, candesartan, Cardiovascular disease, Lipoprotein, Primary Prevention, statinAutores:Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Gao P., Hart R.G., Held C., Khunti K., Leiter L.A., Lewis B.S., Lonn E.M., Pais P., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Reid C.M., Sliwa K., Toff W.D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusUrinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
ArticleAbstract: Although low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as publicPalabras claves:Blood pressure, Hypertension, Intracerebral Hemorrhage, Ischemic stroke, potassium, Sodium, strokeAutores:Al Hussain F., Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.M., DIaz R., ElSayed A., Ferguson J., Hankey G.J., Iversen H.K., Judge C., Lanas F.T., Langhorne P., Lisheng L., Málaga G., Mondo C.K., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Smyth A., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H.Fuentes:googlescopus